- Report
- May 2024
- 281 Pages
Global
From €3323EUR$3,500USD£2,803GBP
€4747EUR$5,000USD£4,004GBP
- Report
- July 2024
- 157 Pages
Global
From €4035EUR$4,250USD£3,403GBP
- Report
- November 2023
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
The Tumor Embolization Device market is a segment of the Medical Devices industry. It is composed of products used to treat tumors by blocking their blood supply. These devices are typically inserted into the body through a catheter, and can be used to treat tumors in the liver, kidney, and other organs. The devices are designed to be minimally invasive, and can be used to treat tumors that are not suitable for surgery.
The Tumor Embolization Device market is expected to grow in the coming years due to the increasing prevalence of cancer and the need for minimally invasive treatments. Additionally, technological advancements in the field are expected to drive market growth.
Some companies in the Tumor Embolization Device market include Boston Scientific, Cook Medical, Merit Medical Systems, and Terumo Corporation. Show Less Read more